S 3258
Passed a chamber
Requires the FAA to publish and maintain a public list of medications that airmen and air traffic control specialists may use for medical certification, along with the medications on its "Do Not Issue" or "Do Not Fly" lists.
Official title: Aviation Medication Transparency Act of 2026
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Received
01-OCT-2026
Senate
Introduced
20-NOV-2025
Referred
20-NOV-2025
Approved by committee
22-JUL-2026
Reported
14-SEP-2026
On the calendar
14-SEP-2026
Passed
24-SEP-2026
- Requires the FAA to publish and maintain, within one year, a public list of medications it has approved for airmen and air traffic control specialists' medical certification or clearance.
- Requires the list to include contraindications for each approved medication, whether each needs FAA review, and the medications designated "Do Not Issue" or "Do Not Fly."
- Requires the FAA to consult pilot and controller representatives, accredited aviation schools, the Civil Aviation Medical Association, and others before release, and to post the list on MedXPress.
- Requires updates within one year of publication and whenever the Guide for Aviation Medical Examiners is revised, and states the FAA is not liable for harm from someone relying on the list.
Covers an older version. The newest CRS summary describes the bill as of "Introduced in Senate" (20-NOV-2025); the text has changed since (Engrossed in Senate, 24-SEP-2026).
CRS is the Library of Congress's nonpartisan research office. Read it on congress.govTransportation and Public Works
■ 11 D■ 3 R
11 Democrats
3 Republicans